Twenty Years of The Magnificent Seven

To any movie buff, TM7 refers to the 1960 John Sturges movie, The Magnificent Seven, in which a 30-year-old Steve McQueen burst onto the scene fighting alongside Yul Brynner, Charles Bronson, Robert Vaughn, and James Coburn to defend the homes of an oppressed Mexican peasant village.

Written byThomas Sakmar
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

Karina Aberg

To any movie buff, TM7 refers to the 1960 John Sturges movie, The Magnificent Seven, in which a 30-year-old Steve McQueen burst onto the scene fighting alongside Yul Brynner, Charles Bronson, Robert Vaughn, and James Coburn to defend the homes of an oppressed Mexican peasant village. But flip it to 7TM and it's a different allusion altogether. Nowadays every biomedical scientist knows that 7TM refers to a receptor class, the G protein-coupled receptors (GPCRs), which have taken center stage in drug discovery and the study of cellular growth and differentiation.

But considering the amount of information about the pharmacology of these receptors acquired over the past several decades, it is surprising that we don't know more about how they really work. How does an agonist ligand activate a receptor? How is ligand specificity achieved? Why can't pharmacophores for specific receptors be designed de novo? Of course, the simple ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies